Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022
Author Name : |
ISRA' MAHMOUD KHALAF DMOUR |
Title : |
Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 |
Journal : |
Journal of Pharmaceutical Innovation |
Year : |
2022 |
Research Area :
|
Compounding Pharmacy, Regulatory Affairs
|
Journal URL :
|
Visit Url
|
|